Literature DB >> 27714582

Galactose alters markers of oxidative stress and acetylcholinesterase activity in the cerebrum of rats: protective role of antioxidants.

Daniela Delwing-de Lima1,2, Monique Fröhlich2, Leticia Dalmedico3, Juliana Gruenwaldt Maia Aurélio3, Débora Delwing-Dal Magro4, Eduardo Manoel Pereira3, Angela T S Wyse5.   

Abstract

We evaluated the in vitro effects of galactose at 0.1, 3.0, 5.0 and 10.0 mM on thiobarbituric acid-reactive substances (TBA-RS), total sulfhydryl content, protein carbonyl content, on the activities of the antioxidant enzymes catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and on acetylcholinesterase (AChE) activity in the cerebral cortex, cerebellum and hippocampus of rats. We also investigated the influence of the antioxidants (each at 1 mM), α-tocopherol, ascorbic acid and glutathione, on the effects elicited by galactose on the parameters tested. Results showed that galactose, at a concentration of 3.0 mM, enhanced TBA-RS levels in the hippocampus, cerebral cortex and cerebellum of rats. In the cerebral cortex, galactose at concentrations of 5.0 and 10.0 mM increased TBA-RS and protein carbonyl content, and at 10.0 mM increased CAT activity and decreased AChE activity. In the cerebellum, galactose at concentrations of 5.0 and 10.0 mM increased TBA-RS, SOD and GSH-Px activities. In the hippocampus, galactose at concentrations of 5.0 and 10.0 mM increased TBA-RS and CAT activity and at 10.0 mM decreased GSH-Px. Data showed that at the pathologically high concentration (greater than 5.0 mM), galactose induces lipid peroxidation, protein carbonylation, alters antioxidant defenses in the cerebrum, and also alters cholinesterase activity. Trolox, ascorbic acid and glutathione addition prevented the majority of alterations in oxidative stress parameters and the decrease in AChE activity that were caused by galactose. Our findings lend support to a potential therapeutic strategy for this condition, which may include the use of appropriate antioxidants for ameliorating the damage caused by galactose.

Entities:  

Keywords:  Acetylcholinesterase; Antioxidant; Cerebrum; Galactose; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27714582     DOI: 10.1007/s11011-016-9915-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

Review 1.  Cell culture, oxidative stress, and antioxidants: avoiding pitfalls.

Authors:  Barry Halliwell
Journal:  Biomed J       Date:  2014 May-Jun       Impact factor: 4.910

2.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay.

Authors:  A Z Reznick; L Packer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 3.  The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase.

Authors:  Thomas J McCorvie; David J Timson
Journal:  IUBMB Life       Date:  2011-07-25       Impact factor: 3.885

4.  Suckling rat brain regional distribution of acetylcholinesterase activity in galactosaemia in vitro.

Authors:  Kyriakoula Marinou; Stylianos Tsakiris; Christi Tsopanakis; Kleopatra H Schulpis; Panagiotis Behrakis
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

5.  Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy: structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene.

Authors:  E Viggiano; A Marabotti; A P Burlina; C Cazzorla; M R D'Apice; L Giordano; I Fasan; G Novelli; A Facchiano; A B Burlina
Journal:  Gene       Date:  2015-01-13       Impact factor: 3.688

6.  Oral administration of d-galactose induces cognitive impairments and oxidative damage in rats.

Authors:  Josiane Budni; Robson Pacheco; Sabrina da Silva; Michelle Lima Garcez; Francielle Mina; Tatiani Bellettini-Santos; Jesiel de Medeiros; Bruna Constantino Voss; Amanda Valnier Steckert; Samira da Silva Valvassori; João Quevedo
Journal:  Behav Brain Res       Date:  2015-12-31       Impact factor: 3.332

7.  Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis.

Authors:  Jun Lu; Dong-mei Wu; Yuan-lin Zheng; Bin Hu; Zi-feng Zhang
Journal:  Brain Pathol       Date:  2009-09-21       Impact factor: 6.508

Review 8.  Galactose-1-phosphate in the pathophysiology of galactosemia.

Authors:  R Gitzelmann
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 9.  Purple sweet potato colour--a potential therapy for galactosemia?

Authors:  David J Timson
Journal:  Int J Food Sci Nutr       Date:  2013-11-26       Impact factor: 3.833

10.  Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide.

Authors:  Joana Barbosa Melo; Paula Agostinho; Catarina Resende Oliveira
Journal:  Neurosci Res       Date:  2003-01       Impact factor: 3.304

View more
  2 in total

1.  Antioxidant and antidepressant-like effects of Eugenia catharinensis D. Legrand in an animal model of depression induced by corticosterone.

Authors:  Sara Cristiane Barauna; Débora Delwing-Dal Magro; Maitê Beatriz Brueckheimer; Thayná P Maia; Geraldo Antonio Bunick Neto Sala; André Wolff Döhler; Mateus Campestrini Harger; Dayse Fabiane Machado de Melo; André Luís de Gasper; Michele Debiasi Alberton; Diogo Alexandre Siebert; Gustavo Amadeu Micke; Cláudia Almeida Coelho de Albuquerque; Daniela Delwing-De Lima
Journal:  Metab Brain Dis       Date:  2018-08-22       Impact factor: 3.584

2.  Effects of resveratrol on alterations in cerebrum energy metabolism caused by metabolites accumulated in type I citrullinemia in rats.

Authors:  Karine Louize Vincenzi; Thayna Patachini Maia; Larissa Delmônego; Aline Barbosa Lima; Luana Carla Pscheidt; Débora Delwing-Dal Magro; Daniela Delwing-de Lima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.